DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model.
Mirco CompagnoneEleonora PintoErika SalvatoriLucia LioneAntonella ConfortiSilvia MarcheseMicol RavàKathryn RyanYper HallEmma RaynerFrancisco Javier SalgueroJemma PatersonMatteo IannaconeRaffaele de FrancescoLuigi AurisicchioFabio PalomboPublished in: Vaccines (2022)
The COVID-19 pandemic is entering a new era with the approval of many SARS-CoV-2 vaccines. In spite of the restoration of an almost normal way of life thanks to the immune protection elicited by these innovative vaccines, we are still facing high viral circulation, with a significant number of deaths. To further explore alternative vaccination platforms, we developed COVID- e Vax-a genetic vaccine based on plasmid DNA encoding the RBD domain of the SARS-CoV-2 spike protein. Here, we describe the correlation between immune responses and the evolution of viral infection in ferrets infected with the live virus. We demonstrate COVID- e Vax immunogenicity as means of antibody response and, above all, a significant T-cell response, thus proving the critical role of T-cell immunity, in addition to the neutralizing antibody activity, in controlling viral spread.
Keyphrases